Skip to content
healthcare.dev

Amlodipine and Atorvastatin

NDC 66993-264, Amlodipine and Atorvastatin, tablet, coated, from Prasco Laboratories.

Product NDC
66993-264
Status
Listed
Labeler
Prasco Laboratories
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021540
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66993-264 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMLODIPINE BESYLATE2.5 mg/1
  • ATORVASTATIN CALCIUM TRIHYDRATE20 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]; HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
66993-264-306699302643030 TABLET, COATED in 1 BOTTLE (66993-264-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/14124e56-77ba-426d-8f5a-dbe42eda1a20
  • NADAC price for package 66993026430

    GET /v1/drugs/nadac/66993026430

Use it

Look up 66993-264 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66993-264 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66993-264. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.